xylazine has been researched along with sk&f 104078 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akers, I; Coates, J; Drew, GM; Sullivan, AT | 1 |
Bao, JX; Gonon, F; Stjärne, L | 1 |
Connaughton, S; Docherty, JR | 1 |
3 other study(ies) available for xylazine and sk&f 104078
Article | Year |
---|---|
Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Azepines; Benzazepines; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vas Deferens; Xylazine | 1991 |
Electrochemical and electrophysiological analysis of the effects of SK&F 104078 on prejunctional alpha 2-adrenoceptors.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arteries; Benzazepines; Cocaine; Drug Interactions; Electric Stimulation; Electrochemistry; Electrophysiology; Male; Mice; Neuromuscular Junction; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Tail; Vas Deferens; Xylazine | 1991 |
Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Benzazepines; Decerebrate State; Heart; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Saphenous Vein; Xylazine | 1988 |